ADCT
#3772
ADC Therapeutics SA Common Shares
1.1 4 USD
+0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.79%
Monthly Change
+0.88%
6 month change
-71.50%
Year Change
-63.11%
Previous Close
1.1 2
Open
1.1 5
Low
1.1 4
High
1.1 7
Volume
323
Financials
- Market Capitalization 145.54 M
- Employee 193
- Founded 2011
- CEO N/A
- Website www.adctherapeutics.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.15
Price to sales ratio
5.51
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3751 |  EQ Equillium, Inc. - Common Stock | 2.39 USD | -2.45% | +4.37% | +4.37% | +43.11% | 151.55 M USD | ||
| 3767 |  UNCY Unicycive Therapeutics, Inc. - Common Stock | 5.27 USD | -4.18% | -6.56% | +10.71% | -19.05% | 146.80 M USD | ||
| 3775 |  MIST Milestone Pharmaceuticals Inc. - Common Shares | 1.16 USD | -2.52% | +9.43% | +11.54% | -36.96% | 144.42 M USD | ||
| 3786 |  CNTB Connect Biopharma Holdings Limited - American Depositary Shares | 2.23 USD | -2.19% | -5.51% | +8.78% | +8.78% | 140.43 M USD |
Frequently asked questions about ADC Therapeutics SA
What is the ADC Therapeutics SA stock price today?
The current price of ADC Therapeutics SA (ADCT) is 1.14. Over the past 24 hours, the stock has changed by +1.79%. Follow the ADCT chart for real-time price dynamics.
What is the stock ticker of ADC Therapeutics SA?
ADC Therapeutics SA trades under the ticker ADCT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is ADC Therapeutics SA stock going up?
ADCT has changed by +14.00% over the last week, +0.88% over the last month, and -63.11% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of ADC Therapeutics SA?
ADC Therapeutics SA currently has a market capitalization of 145.54 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were ADC Therapeutics SA earnings last quarter?
Last quarter, ADC Therapeutics SA reported earnings of -0.11 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was ADC Therapeutics SA revenue for the last quarter?
ADC Therapeutics SA reported quarterly revenue of 19.25 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was ADC Therapeutics SA net income for the last quarter?
ADC Therapeutics SA reported net income of -16.57 M for the last quarter. The previous quarter showed -32.97 M, which means net income changed by +49.75%.
How many employees does ADC Therapeutics SA have?
As of the latest available data, ADC Therapeutics SA has 193 employees. Workforce size can provide additional context about the company's scale and operations.
What is ADC Therapeutics SA EBITDA?
ADC Therapeutics SA EBITDA is -17.11 M, and its EBITDA margin is -88.89%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy ADC Therapeutics SA stock?
You can buy ADC Therapeutics SA (ADCT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in ADC Therapeutics SA stock?
Investing in ADC Therapeutics SA requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ADCT chart and related analysis on metatrader.com as part of your research.